Description

Final outcome data from the exploratory IBS trial summarize the overall impact of the probiotic combination on symptom-psychology interactions. Biomarker trajectories suggest a bidirectional relationship between gut and brain responses.

Figure 7

Chart

Source Paper

Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.

Neurogastroenterology and motility (2023)

PMID: 36178333

DOI: 10.1111/nmo.14477

Cite This Figure

![Figure 7: Final outcome data from the exploratory IBS trial summarize the overall impact of the probiotic combination on symptom-psychology interactions. Biomarker trajectories suggest a bidirectional relationship between gut and brain responses.]()

> Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." *Neurogastroenterology and motility*, 2023. PMID: [36178333](https://pubmed.ncbi.nlm.nih.gov/36178333/)

<figure>
  <img src="" alt="Final outcome data from the exploratory IBS trial summarize the overall impact of the probiotic combination on symptom-psychology interactions. Biomarker trajectories suggest a bidirectional relationship between gut and brain responses." />
  <figcaption>Figure 7. Final outcome data from the exploratory IBS trial summarize the overall impact of the probiotic combination on symptom-psychology interactions. Biomarker trajectories suggest a bidirectional relationship between gut and brain responses.<br>  Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." <em>Neurogastroenterology and motility</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36178333/">36178333</a></figcaption>
</figure>

Related Evidence

Bifidobacterium longum for Irritable Bowel Syndrome (IBS)

Grade B · 4 studies